• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

RESTYLANE STUDIED

Article

Restylane, a new facial filler, may soon be FDA approved. In a study of 2,241 Brazilian patients conducted by Drs. Stephen Bosniak and Marian Cantisano-Zilkha between 1996 and 2001, patients who were treated with Restylane were found to have virtually no allergic reactions.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.